UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation

PloS one, 2010-03, Vol.5 (3), p.e9923-e9923

2010

Volltextzugriff (PDF)

Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

British journal of haematology, 2004-07, Vol.126 (1), p.85-92

2004

Volltextzugriff (PDF)

Effects of selective α1- and α2-adrenergic blockade on coronary flow reserve after coronary stenting

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2901-2907

2002

Volltextzugriff (PDF)

Disproportionate Hyperproinsulinemia, β-Cell Restricted Prohormone Convertase 2 Deficiency, and Cell Cycle Inhibitors Expression by Human Islets Transplanted into Athymic Nude Mice: Insights into Nonimmune-Mediated Mechanisms of Delayed Islet Graft Failure

Cell transplantation, 2008-01, Vol.17 (12), p.1323-1336

2008

Volltextzugriff (PDF)

Non infective severe aortic paravalvular leakage 7 years after surgery: the role of suture technique

Journal of cardiothoracic surgery, 2011-04, Vol.6 (1), p.60-60, Article 60

2011

Volltextzugriff (PDF)

Peri-interventional coronary vasomotion

Journal of molecular and cellular cardiology, 2012-04, Vol.52 (4), p.883-889

2012

Volltextzugriff (PDF)

Ticlopidine and Aspirin Pretreatment Reduces Coagulation and Platelet Activation During Coronary Dilation Procedures

Journal of the American College of Cardiology, 1997-01, Vol.29 (1), p.13-20

1997

Volltextzugriff (PDF)

α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

Circulation (New York, N.Y.), 2000-02, Vol.101 (6), p.689-694

2000

Volltextzugriff (PDF)

α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

Circulation (New York, N.Y.), 1999-02, Vol.99 (4), p.482-490

1999

Volltextzugriff (PDF)

Coronary Vasodilator Capacity and Epicardial Vessel Remodeling in Physiological and Hypertensive Hypertrophy

Hypertension (Dallas, Tex. 1979), 2000-09, Vol.36 (3), p.343-349

2000

Volltextzugriff (PDF)

Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin‐converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation

British journal of haematology, 2005-07, Vol.130 (1), p.113-120

2005

Volltextzugriff (PDF)

Effects of selective (alpha)(1)- and (alpha)(2)-adrenergic blockade on coronary flow reserve after coronary stenting

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2901

2002

Volltextzugriff (PDF)

The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

The American heart journal, 2004-02, Vol.147 (2), p.E6-E6

2004

Volltextzugriff (PDF)

Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents

Circulation (New York, N.Y.), 1994-08, Vol.90 (2), p.895-907

1994

Volltextzugriff (PDF)

Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents

Journal of the American College of Cardiology, 1998-04, Vol.31 (5), p.992-1001

1998

Volltextzugriff (PDF)

EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE

The Lancet (British edition), 1983-09, Vol.322 (8352), p.695-698

1983

Volltextzugriff (PDF)

The ?1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

The American heart journal, 2004-02, Vol.147 (2), p.E6

2004

Volltextzugriff (PDF)

The α1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

The American heart journal, 2004-02, Vol.147 (2), p.323

2004

Volltextzugriff (PDF)

Evaluation of an Index of Peripheral Vascular Resistance in Human Subjects

Journal of hypertension, 1985-12, Vol.3 (6), p.621-629

1985

Volltextzugriff (PDF)

The α 1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

The American heart journal, 2004, Vol.147 (2), p.323-323

2004

Volltextzugriff (PDF)

1079-102 Correlation between norepinephrine and epinephrine myocardial spillover and tumor necrosis factor-alpha in conventional versus off-pump coronary artery bypass surgery

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A274-A274

2004

Volltextzugriff (PDF)

Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings

Circulation research, 1983-07, Vol.53 (1), p.96-104

1983

Volltextzugriff (PDF)

(Alpha)-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

Circulation (New York, N.Y.), 1999-02, Vol.99 (4), p.482

1999

Volltextzugriff (PDF)

Limitation of Coronary Reserve After Successful Angioplasty is Prevented by Oral Pretreatment with an α1-Adrenergic Antagonist

Journal of cardiovascular pharmacology, 2000-09, Vol.36 (3), p.310-315

2000

Volltextzugriff (PDF)

Effects of Selective α 1 - and α 2 -Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2901-2907

2002

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation

Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

Effects of selective α1- and α2-adrenergic blockade on coronary flow reserve after coronary stenting

Disproportionate Hyperproinsulinemia, β-Cell Restricted Prohormone Convertase 2 Deficiency, and Cell Cycle Inhibitors Expression by Human Islets Transplanted into Athymic Nude Mice: Insights into Nonimmune-Mediated Mechanisms of Delayed Islet Graft Failure

Non infective severe aortic paravalvular leakage 7 years after surgery: the role of suture technique

Peri-interventional coronary vasomotion

Ticlopidine and Aspirin Pretreatment Reduces Coagulation and Platelet Activation During Coronary Dilation Procedures

α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

Coronary Vasodilator Capacity and Epicardial Vessel Remodeling in Physiological and Hypertensive Hypertrophy

Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin‐converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation

Effects of selective (alpha)(1)- and (alpha)(2)-adrenergic blockade on coronary flow reserve after coronary stenting

The alpha1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents

Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents

EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE

The ?1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

The α1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

Evaluation of an Index of Peripheral Vascular Resistance in Human Subjects

The α 1-adrenergic blocker urapidil improves contractile function in patients 3 months after coronary stenting: a randomized, double-blinded study

1079-102 Correlation between norepinephrine and epinephrine myocardial spillover and tumor necrosis factor-alpha in conventional versus off-pump coronary artery bypass surgery

Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings

(Alpha)-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

Limitation of Coronary Reserve After Successful Angioplasty is Prevented by Oral Pretreatment with an α1-Adrenergic Antagonist

Effects of Selective α 1 - and α 2 -Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting

Suchergebnisse filtern